Single and combined use of human parathyroid hormone (PTH) (1-34) on areal bone mineral density (aBMD) in postmenopausal women with osteoporosis: evidence based on 9 RCTs

Human parathyroid hormone (PTH) (1-34) or teriparatide (TPTD) is an anabolic agent for osteoporosis. This recombinant protein stimulates positive bone formation balance and bone remodeling. However, when concomitantly used with antiresorptive (AR) agents, previous studies reported conflicting result...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medical science monitor 2014-12, Vol.20, p.2624-2632
Hauptverfasser:	Song, Jiefu, Jin, Zhizhen, Chang, Feng, Li, Lijun, Su, Yunxing
Format:	Artikel
Sprache:	eng
Schlagworte:	Bone Density - drug effects Drug Therapy, Combination Female Femur Neck - drug effects Femur Neck - physiopathology Hip - physiopathology Humans Lumbar Vertebrae - drug effects Lumbar Vertebrae - physiopathology Meta-Analysis Osteoporosis, Postmenopausal - drug therapy Osteoporosis, Postmenopausal - physiopathology Publication Bias Randomized Controlled Trials as Topic Teriparatide - pharmacology Teriparatide - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!